Treatment Protocols Patient Care Evidence-Based Practice Risk Assessment Research Studies Standard of Care Evidence-Based Medicine Best Practices Patient Monitoring Patient Management
Amgen plans to use lower starting doses with gradual escalation to improve tolerability ahead of expanded Phase 3 studies